Jeffrey N. Hausfeld Appointed As Director of NexGen Medical Systems
Monday, October 24th, 2011
MELBOURNE, FL – NexGen Medical Systems, Inc., a medical device company based in Melbourne FL and Reno NV, today announced the appointment of Jeffrey N. Hausfeld, M.D., M.B.A. as a Director of the Company.
“We are delighted to welcome Jeff to the NexGen team,” said CEO John Kucharczyk. “He has had a long and distinguished career as a physician, and also has valuable senior management and financing experience. His expertise in technology development, intellectual property creation and venture financing will bring great value to the Company”, Kucharczyk added.
After graduating from the MBA Program in the Business of Health Program at Johns Hopkins in 2005 and retiring from the practice of Otolaryngology, Dr. Hausfeld represented three major pharmaceutical companies as their national spokesperson. In 2006, he completed a graduate certificate program at George Washington University in Leadership Coaching and Organizational Development. Dr. Hausfeld is currently one of the Managing Directors of FMS Financial Solutions, a national debt collection and debt acquisition firm specializing in medical debt collection. Over the past two years he has been working to syndicate a healthcare related real estate venture where a new entity, Memory Care Communities of Illinois LLC, will construct ten Assisted Living facilities in the Midwest specializing in the care of Alzheimer’s and dementia patients. Through the contributions of Hedge Funds and private equity investors, he has raised six million dollars in commitments. He continues to strive to achieve “Centers of Excellence” through his contacts with the Alzheimer’s Association of America as well as universities specializing in geriatrics and neurosciences. In 2011, Dr. Hausfeld became Cofounder and Treasurer of the Society of Physician Entrepreneurs, a nonprofit organization whose mission is to assist healthcare providers in commercializing their innovations through networking, education and sharing their experiences.
“Great companies are built around the integrity of their leaders, the vision of their technological applications, and the ability of the management team to accurately assess market need and successfully fill that gap. I am proud to join the Board of Directors of NexGen Medical Systems and to assist them in bringing life-changing innovations to the medical marketplace”, said Jeff Hausfeld.
About NexGen, Inc
NexGen Medical Systems is a development stage company that designs medical devices that improve the safety and efficacy of interventional procedures in patients with neurological and cardiovascular diseases. NexGen’s R&D and product development center is located in Melbourne, FL.
NexGen Medical Systems is developing three medical device products that address urgent clinical needs in the interventional radiology and neurosurgery markets. NexGen Medical Systems’ first product is a proprietary catheter-based blood clot retriever that is indicated for the removal of embolic/thrombotic material, including thrombus from peripheral blood vessels and peripheral bypass grafts, clotted synthetic dialysis grafts and arterio-venous fistulas. Initial studies in human patients have shown the XCOILTM Retractor to be safe, easy to use, and effective in retrieving clots from vessels in peripheral blood vessels. The Company is also adapting its platform design for peripheral arterial applications in patients with deep vein thrombosis, and for cerebrovascular thrombectomy applications in ischemic stroke patients.
NexGen Medical Systems’ second product being developed is a brain trauma device for monitoring and treating patients with acute head injury. This catheter-based device will provide combined monitoring and treatment capability not found in currently marketed devices. The Company believes that its brain trauma device will dramatically simplify treatment of acute brain injury patients by eliminating the need for implanting multiple intracranial devices.
NexGen Medical Systems’ third medical device product line is comprised of acute and chronic neurological delivery catheters. The Company’s acute delivery catheter is a proprietary medical device for drug and cell therapy of the central nervous system in patients with tumors, neurodegenerative diseases, and stroke. EViTAR-I is indicated for “the injection of material into, or the removal of material from, the brain during intracranial procedures.”
For additional information about NexGen Medical Systems, please contact John Kucharczyk, Chief Executive Officer, (775) 851-7337, fax (321) 728-0127, email: firstname.lastname@example.org